Visit https://www.peervoice.com/EQD860 to view the entire programme with slides. After completing “Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies”, participants will be able to: Evaluate recent clinical data for current first-line treatment options in patients with advanced EGFR-mutant NSCLC, within the context of long-term care; Discuss strategies and options for managing specific challenges that can impact first-line treatment selection in patients with advanced EGFR-mutant NSCLC; and Formulate optimal treatment strategies that maximise outcomes in patients with advanced EGFR-mutant NSCLC.